Special 510(k) Premarket Notification , Page 14

CoolTouch LC225/CoolLipo Nd:YAG Laser System JUN 9 0 2008

June 9, 2008

eal ee

Premarket Notification 510(k) Summary
CoolTouch LC225/CoolTouch CoolLipo Nd:YAG Laser System
This 5100K) Summary of safety and effectiveness for the CoolTouch LC225/CoolTouch CoolLipo
Nd:YAG surgical laser system is submitted in accordance with the requirements of 21CFR 807.92.

Applicant: New Star Lasers, Inc. dba CoolTouch, Inc.

Address: 9085 Foothills Boulevard
Roseville, CA 95747

Contact Person: Natalie R. Vollrath

Telephone: (916) 677-1900

Fax: (916) 677-1901

Preparation Date: June 9, 2008

Device Trade Name: CoolTouch LC225/CoolTouch CoolLipo Nd:YAG Surgical .
Laser

Common Name: Nd:YAG Pulsed Surgical Laser

Classification Name: Instrument, Surgical Powered, Laser 79-GEX

Legally Marketed Predicate CoolTouch LC215/CoolTouch CoolLipo

Device: Nd:YAG Laser System

Description of the CoolTouch The LC225/CoolLipo Nd:YAG Laser System produces laser

LC225/CoolLipo Nd:YAG emission at 1320nm. The laser consists of three

Surgical Laser: interconnected sections: the cabinet which houses the power
supply, the cooling system, the microcontroller and the laser,
the fiber optics, and the handpiece or JouleTracker

Intended use of the CoolTouch For use in dermatology for incision, excision, ablation and

1.C225/ CoolLipo Nd:Y AG vaporization with hemostasis of soft tissue. For use in the

Surgical Laser: treatment of fine lines and wrinkles. For treatment of back
acne and atrophic acne scars. For treatment of reflux of the
great and small saphenous veins associated with varicose
veins and varicosities. For laser-assisted lipolysis.

Performance Data: None

Conclusion: Based on the evaluation of the risks and hazards and
including various testing of the modifications, the
CoolTouch LC225/CoolLipo Nd:YAG Surgical Laser
System is substantially equivalent to the predicate device,
the LC215.

Confidential 0 0 1 4

= J DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
G Food and Drug Administration
9200 Corporate Boulevard
Rackville MD 20850
JUN 20 2008
New Star Lasers, Inc.
% Ms. Natalie R. Vollrath
Quality Assurance/Regulatory Affairs
Manager
9085 Foothills Boulevard
Roseville, Califormia 95747
Re: K081628 ;
Trade/Device Name: CoolTouch LC225/CoolTouch CoolLipo
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery
and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: June 9, 2008
Received: June 10, 2008
Dear Ms. Vollrath:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class Il (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set

Page 2 — Ms, Natalie R. Vollrath
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to procecd to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance at
(240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification” (21CFR Part 807.97). For questions regarding postmarket surveillance,
please contact CDRH’s Office of Surveillance and Biometric’s (OSB’s) Division of Postmarket
Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events
(Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems
at (240) 276-3464, You may obtain other general information on your responsibilities under the
Act from the Division of Small Manufacturers, International and Consumer Assistance
at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address
http://www. fda. gov/cdrh/industry/support/index.html. :

Sincerely yours,

Mark N. Melkerson

Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
. Enclosure

Special 510(k) Premarket Notification Page 10
CoolTouch LC225/CoolLipo Nd:YAG Laser System
June 9, 2008
eee
510(k) Number Pending
Device Name CoolTouch LC225/CoolTouch CoolLipo
Indications for The CoolTouch Model LC225/CoolTouch CoolLipo Nd:YAG
: Use Surgical Laser is indicated for the following:
a) for use in dermatology for incision, excision, ablation and
vaporization with hemostasis of soft tissue;
b) for use in the treatment of fine lines and wrinkles;
c) for treatment of back acne and atrophic acne scars;
d) for treatment of reflux of the great and small saphenous
veins associated with varicose veins and varicosities, and:
e) for laser-assisted lipolysis.
Prescription Use X AND/OR Over-the-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE —- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
aye hn ent
(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices Page _1 of 1.
510(k) Number_0% (62.8
Confidential 0 0 1 0

